Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Nat Commun. 2023 Aug 22;14(1):5092. doi: 10.1038/s41467-023-40896-5.
Clonal tracking of cells using somatic mutations permits exploration of clonal dynamics in human disease. Here, we perform whole genome sequencing of 323 haematopoietic colonies from 10 individuals with the inherited ribosomopathy Shwachman-Diamond syndrome to reconstruct haematopoietic phylogenies. In ~30% of colonies, we identify mutually exclusive mutations in TP53, EIF6, RPL5, RPL22, PRPF8, plus chromosome 7 and 15 aberrations that increase SBDS and EFL1 gene dosage, respectively. Target gene mutations commence in utero, resulting in a profusion of clonal expansions, with only a few haematopoietic stem cell lineages (mean 8, range 1-24) contributing ~50% of haematopoietic colonies across 8 individuals (range 4-100% clonality) by young adulthood. Rapid clonal expansion during disease transformation is associated with biallelic TP53 mutations and increased mutation burden. Our study highlights how convergent somatic mutation of the p53-dependent nucleolar surveillance pathway offsets the deleterious effects of germline ribosomopathy but increases opportunity for TP53-mutated cancer evolution.
利用体细胞突变对细胞进行克隆追踪,可用于研究人类疾病中的克隆动力学。在这里,我们对 10 名遗传性核糖体病 Shwachman-Diamond 综合征患者的 323 个造血集落进行了全基因组测序,以重建造血系统进化关系。在大约 30%的集落中,我们鉴定出 TP53、EIF6、RPL5、RPL22、PRPF8 以及 7 号和 15 号染色体异常的互斥突变,这些异常分别增加了 SBDS 和 EFL1 基因的拷贝数。靶基因突变起始于胎儿期,导致大量克隆扩增,只有少数造血干细胞谱系(平均值为 8,范围为 1-24)在成年早期(范围为 4-100%的克隆性)对 8 名个体中约 50%的造血集落做出贡献。疾病转化过程中的快速克隆扩增与双等位 TP53 突变和突变负担增加有关。我们的研究强调了 p53 依赖性核仁监测途径的协同体细胞突变如何抵消了种系核糖体病的有害影响,但增加了 TP53 突变癌症进化的机会。